Vairavan Latha

Vairavan Latha is listed in filings as SVP Chief Financial Officer at Arcutis Biotherapeutics, Inc. - Common stock. This profile follows SEC Form 4 activity through May 13, 2026, including sale activity. Recent filings connect the profile to Arcutis Biotherapeutics, Inc. - Common stock (ARQT). The current snapshot covers public activity from May 7, 2025 to May 13, 2026. Reported amounts are shown as $9.2K to $2.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.